Thrombophilia
What is it?
The prothrombin gene 20210 mutation (Thrombophilia) is a clotting factor that, upon activation of the clotting mechanism, is converted into insoluble thrombin. The 20210 mutation in the prothrombin gene can lead to significantly elevated levels of prothrombin, thereby increasing the risk of thromboembolism.
Where Used
Used in assessing cardiovascular diseases and calculating risk factors for thrombosis. Recommended For Individuals With:
- Personal or family history of thrombosis
- Contraceptive treatment or hormone replacement therapy
- High-risk pregnancies (older age, twins/triplets, etc.)
- Unexplained pregnancy losses
Reference Values -Normal Laboratory :
Negative in mutation prothrombine 20210
PREPARATION
Your tests with analytical systems and reagents top quality SIEMENS-USA BECMAN COULTER-USA
For the morning blood draw and
examination, it is proposed :
A simple blood draw at any time of the day, without food preparation or avoiding medication intake.
Sample Submission Capability
For more information, please contact us at 210.6983.222
TIME OF RESULTS
- Results in 4-5 business days.
COSTING
The private cost for the individual test (Prothrombin Gene 20210 Mutation) is €50*.
According to our latest information, the test for (Prothrombin Gene 20210 Mutation) is NOT covered by EOPYY.
*25% discount applies when participating in Check Up
e – Booking via Doctor Anytime at: Cardiologist – Neurologist– Diagnostic Tests
Informative Blogs: checkup.com.gr – nosileftis24.gr– syntagografisis.gr – testcovid.gr
Biopathology Diagnostic Center – Athens | Medical Center Check Up Medicus | Checkup – Allergy Test – Blood Tests – Prices – Cost – Covid-19 Test | EOPYY.
Panormou Diagnostic Center 40, Ampelokipoi | Diagnostic Center Alexandra Avenue 110 | Diagnostic Center Prykiponnision 24, Gyzi Polygono Kypseli
Appointment
At Check-Up Medicus you can come for a blood draw without an appointment
The checkup for the prothrombin gene 20210 mutation is often included in the laboratory checkup for thrombophilia, a condition that affects the process of blood clotting and bleeding. his mutation leads to an increase in the level of prothrombin, a protein involved in the blood clotting process.
This mutation is associated with an increased risk of thrombosis.
The prothrombin 20210 gene mutation was first detected in individuals with a family history of thromboembolic events. However, it is now known that the mutation can also occur in individuals without a family history. People who carry the mutation have an increased risk of thrombosis.
The checkup for the prothrombin gene 20210 mutation can be crucial for individuals with a history of thromboembolic events or other bleeding disorders, as well as for those with other risk factors. Identifying mutations in this gene can help in taking preventive measures to reduce the risk of thrombosis, such as taking antiplatelet medications or other therapies.